Renoprotective effect of combined inhibition of angiotensin-converting enzyme and histone deacetylase

Journal of the American Society of Nephrology

Volumn 24, Issue 5, 2013, Pages 801-811

  Zhong, Yifei ^a,b   Chen, Edward Y ^a   Liu, Ruijie ^a,d   Chuang, Peter Y ^a   Mallipattu, Sandeep K ^a   Tan, Christopher M ^a   Clark, Neil R ^a   Deng, Yueyi ^b   Klotman, Paul E ^c   Ma'ayan, Avi ^a   He, John Cijiang ^a,d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENAZEPRIL; VORINOSTAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CONTROLLED STUDY; GENE EXPRESSION; HIV ASSOCIATED NEPHROPATHY; KIDNEY FUNCTION; KIDNEY INJURY; MALE; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; VALIDITY;

EID: 84877091469     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012060590     Document Type: Article

References (39)

1. Maione A, Navaneethan SD, Graziano G, Mitchell R, Johnson D, Mann JF, Gao P, Craig JC, Tognoni G, Perkovic V, Nicolucci A, De Cosmo S, Sasso A, Lamacchia O, Cignarelli M, Manfreda VM, Gentile G, Strippoli GF: Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macro-albuminuria and other cardiovascular risk factors: A systematic review of randomized controlled trials. Nephrol Dial Transplant 26: 2827-2847, 2011
2. Persson F, Rossing P, Schjoedt KJ, Juhl T, Tarnow L, Stehouwer CD, Schalkwijk C, Boomsma F, Frandsen E, Parving HH: Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes. Kidney Int 73: 1419-1425, 2008 (Pubitemid 351770494)
3. Bomback AS, Kshirsagar AV, Amamoo MA, Klemmer PJ: Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: A systematic review. Am J Kidney Dis 51: 199-211, 2008
4. Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF: Aldosterone antagonists for preventing the progression of chronic kidney disease: A systematic review and meta-analysis. Clin J Am Soc Nephrol 4: 542-551, 2009
5. Azizi M, Menard J: Renin Inhibitors and Cardiovascular and Renal Protection: An Endless Quest? [published online ahead of print March 6, 2012] Cardiovasc Drugs Ther doi:10.1007/s10557-012-6380-6
6. Kunz R, Friedrich C, Wolbers M, Mann JF: Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. Ann Intern Med 148: 30-48, 2008 (Pubitemid 351688350)
7. Mancia G: Angiotensin receptor antagonists and increased risk of cancer. Further evidence against. J Hypertens 29: 653-654, 2011
8. Slagman MC, Navis G, Laverman GD: Dual blockade of the renin-angiotensin-aldosterone system in cardiac and renal disease. Curr Opin Nephrol Hypertens 19: 140-152, 2010
9. Redon J, Mancia G, Sleight P, Schumacher H, Gao P, Pogue J, Fagard R, Verdecchia P, Weber M, Böhm M, Williams B, Yusoff K, Teo K, Yusuf S; ONTARGET Investigators: Safety and efficacy of low blood pressures among patients with diabetes: Subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). J Am Coll Cardiol 59: 74-83, 2012
10. Dannenfelser R, Xu H, Raimond C, Ma'ayan A: Network pharmacology to aid the drug discovery process. In: New Frontiers of Network Analysis in Systems Biology, edited by Macarthur AMAAB, Dordrecht, the Netherlands, Springer Science, 2012
11. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR: The Connectivity Map: Using gene-expression signatures to connect small molecules, genes, and disease. Science 313: 1929-1935, 2006 (Pubitemid 44497995)
12. Iorio F, Rittman T, Ge H, Menden M, Saez-Rodriguez J: Transcriptional data: A new gateway to drug repositioning? [published online ahead of print August 7, 2012] Drug Discov Today doi: 10.1016/j.drudis.2012.07.014
13. Jin Y, Ratnam K, Chuang PY, Fan Y, Zhong Y, Dai Y, Mazloom AR, Chen EY, D'Agati V, Xiong H, Ross MJ, Chen N, Ma'ayan A, He JC: A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nat Med 18: 580-588, 2012
14. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD; The Collaborative Study Group: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462, 1993 (Pubitemid 23335891)
15. Pang M, Kothapally J, Mao H, Tolbert E, Ponnusamy M, Chin YE, Zhuang S: Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 297: F996-F1005, 2009
16. Butler LM, Zhou X, Xu WS, Scher HI, Rifkind RA, Marks PA, Richon VM: The histone deacetylase inhibitor SAHA arrests cancer cell growth, upregulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc Natl Acad Sci U S A 99: 11700-11705, 2002 (Pubitemid 34994462)
17. Ogata H, Goto S, Fujibuchi W, Kanehisa M: Computation with the KEGG pathway database. Biosystems 47: 119-128, 1998 (Pubitemid 28369499)
18. Kelder T, van Iersel MP, Hanspers K, Kutmon M, Conklin BR, Evelo CT, Pico AR: WikiPathways: building research communities on biological pathways. Nucleic Acids Res 40[Database issue]: D1301-D1307, 2012
19. Lachmann A, Xu H, Krishnan J, Berger SI, Mazloom AR, Ma'ayan A: ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26: 2438-2444, 2010
20. Lachmann A, Ma'ayan A: KEA: kinase enrichment analysis. Bioinformatics 25: 684-686, 2009
21. Blake JA, Bult CJ, Eppig JT, Kadin JA, Richardson JE; Mouse Genome Database Group: The Mouse Genome Database genotypes:phenotypes. Nucleic Acids Res 37[Database issue]: D712 -D719, 2009
22. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB: A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101: 6062-6067, 2004 (Pubitemid 38520528)
23. Lachmann A, Ma'ayan A: Lists2Networks: integrated analysis of gene/protein lists. BMC Bioinformatics 11: 87, 2010
24. Chen EY, Xu H, Gordonov S, Lim MP, Perkins MH, Ma'ayan A: Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layers. Bioinformatics 28: 105-111, 2012
25. Heyman SN, Rosenberger C, Rosen S: Acute kidney injury: Lessons from experimental models. Contrib Nephrol 169: 286-296, 2011
26. Ma FY, Liu J, Kitching AR, Manthey CL, Nikolic-Paterson DJ: Targeting renal macrophage accumulation via c-fms kinase reduces tubular apoptosis but fails to modify progressive fibrosis in the obstructed rat kidney. Am J Physiol Renal Physiol 296: F177-F185, 2009
27. Ross MJ, Fan C, Ross MD, Chu TH, Shi Y, Kaufman L, Zhang W, Klotman ME, Klotman PE: HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells. J Acquir Immune Defic Syndr 42: 1-11, 2006 (Pubitemid 43947940)
28. Schmid H, Boucherot A, Yasuda Y, Henger A, Brunner B, Eichinger F, Nitsche A, Kiss E, Bleich M, Gröne HJ, Nelson PJ, Schlöndorff D, Cohen CD, Kretzler M; European Renal cDNA Bank (ERCB) Consortium: Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 55: 2993-3003, 2006 (Pubitemid 44923635)
29. Liu Z, Huang XR, Lan HY: Smad3 mediates ANG II-induced hypertensive kidney disease in mice. Am J Physiol Renal Physiol 302: F986-F997, 2012
30. Palm F, Nordquist L: Renal oxidative stress, oxygenation, and hypertension. Am J Physiol Regul Integr Comp Physiol 301: R1229-R1241, 2011
31. Wolf G: Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int 70: 1914-1919, 2006
32. Chen Y, Wang H, Yoon SO, Xu X, Hottiger MO, Svaren J, Nave KA, Kim HA, Olson EN, Lu QR: HDAC-mediated deacetylation of NF-κB is critical for Schwann cell myelination. Nat Neurosci 14: 437-441, 2011
33. Lucas GM, Mehta SH, Atta MG, Kirk GD, Galai N, Vlahov D, Moore RD: End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS 21: 2435-2443, 2007 (Pubitemid 350145175)
34. Wyatt CM, Klotman PE: HIV-associated nephropathy in the era of antiretroviral therapy. Am J Med 120: 488-492, 2007 (Pubitemid 46764627)
35. Dickie P, Felser J, Eckhaus M, Bryant J, Silver J, Marinos N, Notkins AL: HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185: 109-119, 1991
36. Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Dickie P, Marinos NJ, Eckhaus M, Bryant JL, Notkins AL, Klotman PE: Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci U S A 89: 1577-1581, 1992
37. Kumar D, Plagov A, Yadav I, Torri DD, Sayeneni S, Sagar A, Rai P, Adabala M, Lederman R, Chandel N, Ding G, Malhotra A, Singhal PC: Inhibition of renin activity slows down the progression of HIV-associated nephropathy. Am J Physiol Renal Physiol 303: F711-F720, 2012
38. Shimizu A, Zhong J, Miyazaki Y, Hosoya T, Ichikawa I, Matsusaka T: ARB protects podocytes from HIV-1 nephropathy independently of podocyte AT1. Nephrol Dial Transplant 27: 3169-3175, 2012
39. D'Agati V: Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol 23: 117-134, 2003